Perrigo (PRGO) Accounts Payables (2013 - 2026)
Perrigo (PRGO) reported Accounts Payables of $434.8 million for Q1 2026, down 13.44% year-over-year from $502.3 million in Q1 2025, and down 8.37% quarter-over-quarter from $474.5 million in Q4 2025.
Perrigo (PRGO) Accounts Payables (2013 - 2026) Analysis & Trends
Perrigo (PRGO) has 14 years of Accounts Payables data on file, last reported at $434.8 million in Q1 2026.
- Accounts Payables for Q1 2026 came in at $434.8 million, down 13.44% year-over-year; the trailing twelve-month figure through Mar 2026 was $434.8 million (down 13.44% YoY), and the FY2025 annual result was $474.5 million, down 4.18% from the prior year.
- Accounts Payables retreated to $434.8 million in Q1 2026 per PRGO's latest filing, from $474.5 million in the prior quarter.
- Over five years, Accounts Payables peaked at $537.3 million in Q4 2022 and troughed at $433.1 million in Q3 2023.
- A 5-year average of $476.7 million and a median of $474.5 million in 2025 frame the typical range for Accounts Payables.
- The sharpest annual moves came in 2022 and 2026: Accounts Payables soared 30.67% in 2022, then slipped 13.44% in 2026.
- A 5-year view of Accounts Payables shows it stood at $537.3 million in 2022, then decreased by 11.09% to $477.7 million in 2023, then advanced by 3.66% to $495.2 million in 2024, then decreased by 4.18% to $474.5 million in 2025, then declined by 8.37% to $434.8 million in 2026.
- Business Quant data shows PRGO's Accounts Payables at $434.8 million in Q1 2026, $474.5 million in Q4 2025, and $469.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 2.60 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 507.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 498.30 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 48.78 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 773.00 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 372.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 102.36 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 306.87 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 45.88 Mn |
| 10 | Perrigo | 1.55 Bn | 1.19 Bn | 325.50 Mn | 434.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 434.80 Mn |
| Dec 31, 2025 | 474.50 Mn |
| Sep 27, 2025 | 469.70 Mn |
| Jun 28, 2025 | 489.00 Mn |
| Mar 29, 2025 | 502.30 Mn |
| Dec 31, 2024 | 495.20 Mn |
| Sep 28, 2024 | 458.50 Mn |
| Jun 29, 2024 | 471.50 Mn |
| Mar 30, 2024 | 453.70 Mn |
| Dec 31, 2023 | 477.70 Mn |
| Sep 30, 2023 | 433.10 Mn |
| Jul 1, 2023 | 470.50 Mn |
| Apr 1, 2023 | 505.20 Mn |
| Dec 31, 2022 | 537.30 Mn |
| Oct 1, 2022 | 461.40 Mn |
| Jul 2, 2022 | 490.40 Mn |
| Apr 2, 2022 | 479.60 Mn |
| Dec 31, 2021 | 411.20 Mn |
| Oct 2, 2021 | 405.60 Mn |
| Jul 3, 2021 | 402.40 Mn |